Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...

Heidelberg re-launched its Apprenticeship Program. The vocational training initiative has already proven successful.

Ladenburg, Germany, 12 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...

Heidelberg Materials North America announced that the Government of Canada’s Innovation, Science and Economic Development ...

You can read more about 175 years of HEIDELBERG and history on our anniversary website www.heidelberg.com/175, on the current ...

You can read more about 175 years of HEIDELBERG and history on our anniversary website www.heidelberg.com/175, on the current Wikipedia page of the company, in the yearbook "150 years of Heidelberger ...

Heidelberg has put together a fascinating timeline of the firm’s history as part of celebrations to mark its 175th anniversary.

ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...

Georgett McCarty’s son attends third grade at The New William J. Berry Elementary School in Heidelberg. She shared medical ...

The new press is anticipated to boost Peczuh’s efficiency and capacity, supporting its continuous growth and demonstrating ...

Germany’s Heidelberg Pharma (FSE: HPHA) has modified its royalty financing agreement with HealthCare Royalty (HCRx), securing an additional $20 million upfront payment. The amendment extends the ...

Dominik von Achten, the CEO of Heidelberg Materials, discusses the German firm's full-year financial results. Flying car ...